scholarly journals A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 4088-4088
Author(s):  
Ahmed Omar Kaseb ◽  
Humaid Obaid Al-Shamsi ◽  
Jeffrey Morris ◽  
Michiko Iwasaki ◽  
Lianchun Xiao ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

2016 ◽  
pp. 773 ◽  
Author(s):  
Ahmed Kaseb ◽  
Jeffrey Morris ◽  
Michiko Iwasaki ◽  
Humaid Al-Shamsi ◽  
Kanwal Raghav ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study

2013 ◽  
Vol 49 (16) ◽  
pp. 3412-3419 ◽  
Author(s):  
Jordi Bruix ◽  
Won-Young Tak ◽  
Antonio Gasbarrini ◽  
Armando Santoro ◽  
Massimo Colombo ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Safety Study ◽  
Line Therapy ◽  
Open Label Phase

Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

2012 ◽  
Vol 18 (7) ◽  
pp. 2090-2098 ◽  
Author(s):  
Richard S. Finn ◽  
Yoon-Koo Kang ◽  
Mary Mulcahy ◽  
Blase N. Polite ◽  
Ho Yeong Lim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Open Label Study ◽  
Label Study ◽  
Line Therapy

scholarly journals Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial

2019 ◽  
Vol 10 (25) ◽  
pp. 6185-6190
Author(s):  
Seung Tae Kim ◽  
Sung Yong Oh ◽  
Jeeyun Lee ◽  
Jung Hun Kang ◽  
Hyun Woo Lee ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Biliary Tract Cancers ◽  
Line Therapy ◽  
Open Label Phase

Eligibility for Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Erica S. Tsang ◽  
Janine M. Davies ◽  
Jonathan M. Loree ◽  
Howard J. Lim ◽  
Daniel J. Renouf ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document